In case you missed it: Jan. 24 to Jan. 28
It's been a busy week for the Contemporary OB/GYN® team. Here's a look at what you missed.
Estrogen and candida albicans
Research in the journal Cell Reports concludes that the discovery of a hormone-sensing pathway in Candida albicans, which enables the fungus to adapt to estrogen, could help explain gender biases linked to fungal infections and might provide an alternative approach to improving women's health.
Society for Maternal-Fetal Medicine Special Statement: COVID-19 research in pregnancy: progress and potential
The COVID-19 global pandemic has broad implications for obstetrical care and perinatal outcomes. As we approach the 2-year mark into an unprecedented international pandemic, this review presents the progress and opportunities for research related to COVID-19 and pregnancy.
Risk factors for preeclampsia
For preeclampsia, multifetal gestation was the most common high-risk factor among pregnant patients who gave birth in the United States in 2019.
Oral probiotics to prevent vulvovaginal infections in pregnant women
An oral probiotic formula for the secondary prevention of vulvovaginal infections in pregnant women neither colonized in the vagina nor reduced the rate of repeated vulvovaginal infection, according to a study in the American Journal of Gynecology & Obstetrics.
Intimate partner violence linked to shorter interpregnancy interval
May 18th 2025A study presented at the 2025 ACOG Annual Clinical & Scientific Meeting found women who experience intimate partner violence are more likely to have short interpregnancy intervals and mental health disorders.
Read More
